Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road, Scheme-XM, Beliaghata, Kolkata, West Bengal, 700010, India.
Virol J. 2024 Aug 12;21(1):186. doi: 10.1186/s12985-024-02460-5.
The global outbreak of COVID-19 caused by the SARS-CoV-2 has led to millions of deaths. This unanticipated emergency has prompted virologists across the globe to delve deeper into the intricate dynamicity of the host-virus interface with an aim to identify antiviral targets and elucidate host and viral determinants of severe disease.
The present study was undertaken to analyse the role of histone deacetylase 6 (HDAC6) in regulating SARS-CoV-2 infection.
Gradual increase in HDAC6 expression was observed in different SARS-CoV-2-permissive cell lines following SARS-CoV-2 infection. The SARS-CoV-2 nucleocapsid protein (N protein) was identified as the primary viral factor responsible for upregulating HDAC6 expression. Downregulation of HDAC6 using shRNA or a specific inhibitor tubacin resulted in reduced viral replication suggesting proviral role of its deacetylase activity. Further investigations uncovered the interaction of HDAC6 with stress granule protein G3BP1 and N protein during infection. HDAC6-mediated deacetylation of SARS-CoV-2 N protein was found to be crucial for its association with G3BP1.
This study provides valuable insights into the molecular mechanisms underlying the disruption of cytoplasmic stress granules during SARS-CoV-2 infection and highlights the significance of HDAC6 in the process.
由 SARS-CoV-2 引起的 COVID-19 全球大流行导致了数百万人死亡。这场突如其来的紧急情况促使全球病毒学家更深入地研究宿主-病毒界面的复杂动态,以确定抗病毒靶点,并阐明严重疾病的宿主和病毒决定因素。
本研究旨在分析组蛋白去乙酰化酶 6(HDAC6)在调节 SARS-CoV-2 感染中的作用。
在 SARS-CoV-2 感染后,不同的 SARS-CoV-2 允许细胞系中观察到 HDAC6 表达逐渐增加。SARS-CoV-2 核衣壳蛋白(N 蛋白)被确定为上调 HDAC6 表达的主要病毒因子。使用 shRNA 或特异性抑制剂 tubacin 下调 HDAC6 会导致病毒复制减少,表明其去乙酰化酶活性具有促进病毒复制的作用。进一步的研究揭示了在感染过程中 HDAC6 与应激颗粒蛋白 G3BP1 和 N 蛋白的相互作用。发现 HDAC6 介导的 SARS-CoV-2 N 蛋白去乙酰化对于其与 G3BP1 的关联至关重要。
本研究提供了对 SARS-CoV-2 感染过程中细胞质应激颗粒破坏的分子机制的深入了解,并强调了 HDAC6 在该过程中的重要性。